90Y-DOTA-tyr3-Octreotide

90Y-DOTA-tyr3-Octreotide
Trade Name
Orphan Indication Neuroendocrine tumors
USA Market Approval USA
USA Designation Date 2016-01-20 00:00:00
Sponsor M. Sue O'Dorisio, MD, PhD;2519 JPP, 200 Hawkins Drive;Iowa City, Iowa, 52242
Related Access Program
Advanced Accelerator Applications – Neuroendocrine Tumors Andrei Iagaru – Other Neuroendocrine Tumors Jonsson Comprehensive Cancer Center – Neuroendocrine Tumors Memorial Sloan Kettering Cancer Center. – Neuroendocrine Tumors